These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31630399)

  • 1. Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study.
    Rosati A; Boncristiano A; Doccini V; Pugi A; Pisano T; Lenge M; De Masi S; Guerrini R
    Epilepsia; 2019 Nov; 60(11):2255-2262. PubMed ID: 31630399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stiripentol: efficacy and tolerability in children with epilepsy.
    Perez J; Chiron C; Musial C; Rey E; Blehaut H; d'Athis P; Vincent J; Dulac O
    Epilepsia; 1999 Nov; 40(11):1618-26. PubMed ID: 10565591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of add-on stiripentol in real-world clinical practice: An observational study in Dravet syndrome and non-Dravet developmental and epileptic encephalopathies.
    Gil-Nagel A; Aledo-Serrano A; Beltrán-Corbellini Á; Martínez-Vicente L; Jimenez-Huete A; Toledano-Delgado R; Gacía-Morales I; Valls-Carbó A
    Epilepsia Open; 2024 Feb; 9(1):164-175. PubMed ID: 37867433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
    Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
    CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
    Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Starting stiripentol in adults with Dravet syndrome? Watch for ammonia and carnitine.
    Zulfiqar Ali Q; Marques P; Selvarajah A; Tabarestani S; Sadoway T; Andrade DM
    Epilepsia; 2020 Nov; 61(11):2435-2441. PubMed ID: 33084037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study.
    De Liso P; Chemaly N; Laschet J; Barnerias C; Hully M; Leunen D; Desguerre I; Chiron C; Dulac O; Nabbout R
    Epilepsy Res; 2016 Sep; 125():42-6. PubMed ID: 27389706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.
    Chiron C; Marchand MC; Tran A; Rey E; d'Athis P; Vincent J; Dulac O; Pons G
    Lancet; 2000 Nov; 356(9242):1638-42. PubMed ID: 11089822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy.
    Brigo F; Storti M
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010483. PubMed ID: 24254932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
    Myers KA; Lightfoot P; Patil SG; Cross JH; Scheffer IE
    Dev Med Child Neurol; 2018 Jun; 60(6):574-578. PubMed ID: 29473155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol for focal refractory epilepsy.
    Brigo F; Storti M
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009887. PubMed ID: 24488598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stiripentol for the treatment of super-refractory status epilepticus.
    Strzelczyk A; Kortland LM; Knake S; Rosenow F
    Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
    Chiron C; Helias M; Kaminska A; Laroche C; de Toffol B; Dulac O; Nabbout R; An I
    Epilepsia; 2018 Sep; 59(9):1705-1717. PubMed ID: 30132836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).
    Plosker GL
    CNS Drugs; 2012 Nov; 26(11):993-1001. PubMed ID: 23018548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
    Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.